Impaired small-conductance Ca2+-activated K+ channel-dependent EDHF responses in Type II diabetic ZDF rats

Br J Pharmacol. 2006 Jun;148(4):434-41. doi: 10.1038/sj.bjp.0706748. Epub 2006 May 8.

Abstract

We have examined the relative contributions of small- and intermediate-conductance Ca(2+)-activated K(+) channels (SK(Ca) and IK(Ca)) to the endothelium-derived hyperpolarizing factor (EDHF) pathway response in small mesenteric arteries of Zucker Diabetic Fatty (ZDF) rats, before and after the development of Type II diabetes, together with Lean controls. Smooth muscle membrane potential was recorded using sharp microelectrodes in the presence of 10 microM indomethacin plus 100 microM N(omega)-nitro-L-arginine. SK(Ca) was selectively inhibited with 100 nM apamin, whereas IK(Ca) was blocked with 10 microM TRAM-39 (2-(2-chlorophenyl)-2,2-diphenylacetonitrile). Resting membrane potentials were similar in arteries from 17- to 20-week-old control and diabetic rats (approximately -54 mV). Responses elicited by 1 and 10 microM acetylcholine (ACh) were significantly smaller in the diabetic group (e.g. hyperpolarizations to -69.5 +/- 0.8 mV (ZDF; n = 12) and -73.2 +/- 0.6 mV (Lean; n = 12; P < 0.05) evoked by 10 microM ACh). The IK(Ca)-mediated components of the ACh responses were comparable between groups (hyperpolarizations to approximately -65 mV on exposure to 10 microM ACh). However, SK(Ca)-mediated responses were significantly reduced in the diabetic group (hyperpolarizations to -63.1 +/- 1.0 mV (ZDF; n = 6) and -71.5 +/- 1.2 mV (Lean; n = 6; P < 0.05) on exposure to 10 microM ACh. Impaired ACh responses were not observed in arteries from 5- to 6-week-old (pre-diabetic) animals. SK(Ca) subunit mRNA expression was increased in the diabetic group. The EDHF pathway, especially the SK(Ca)-mediated response, is impaired in Type II diabetic ZDF rats without a reduction in channel gene expression. These results may be particularly relevant to the microvascular complications of diabetes. The functional separation of SK(Ca) and IK(Ca) pathways is discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetonitriles / pharmacology
  • Animals
  • Benzimidazoles / pharmacology
  • Biological Factors / physiology*
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Intermediate-Conductance Calcium-Activated Potassium Channels / physiology
  • Male
  • Membrane Potentials / drug effects
  • Rats
  • Rats, Zucker
  • Reverse Transcriptase Polymerase Chain Reaction
  • Small-Conductance Calcium-Activated Potassium Channels / physiology*
  • Trityl Compounds / pharmacology

Substances

  • 2-(2-chlorophenyl)-2,2-diphenyl acetonitrile
  • Acetonitriles
  • Benzimidazoles
  • Biological Factors
  • Intermediate-Conductance Calcium-Activated Potassium Channels
  • Small-Conductance Calcium-Activated Potassium Channels
  • Trityl Compounds
  • endothelium-dependent hyperpolarization factor
  • 1-ethyl-2-benzimidazolinone